Tokyo Tape
Sign in
← Artra Group

Quarterly report · Q1

6029.TEDINET S100TFS8
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥1.0bn2024-01-01 → 2024-03-31Cons.Net sales
Revenue¥4.5bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥1.0bn2023-01-01 → 2023-03-31Cons.Net sales
Operating income−¥27m2024-01-01 → 2024-03-31Cons.Operating income
Operating income−¥68m2023-01-01 → 2023-03-31Cons.Operating income
Ordinary income−¥30m2024-01-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥62m2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥61m2023-01-01 → 2023-03-31Cons.Ordinary income
Profit before tax−¥30m2024-01-01 → 2024-03-31Cons.Income before income taxes
Profit before tax−¥60m2023-01-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)−¥35m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥54m2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥69m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income−¥35m2024-01-01 → 2024-03-31Cons.Profit loss
Net income−¥69m2023-01-01 → 2023-03-31Cons.Profit loss
Total assets¥4.2bnat 2024-03-31Cons.Assets
Total assets¥4.6bnat 2023-12-31Cons.Assets
Total assets¥4.3bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥2.8bnat 2024-03-31Cons.Liabilities
Total liabilities¥3.1bnat 2023-12-31Cons.Liabilities
Net assets / equity¥1.4bnat 2024-03-31Cons.Net assets
Net assets / equity¥1.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥1.2bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥1.1bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-12-31Cons.Cash and deposits
EPS (basic)¥-3.442024-01-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.432023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-7.082023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio33.6%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥900,000
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥597m
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥597m
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥22m
jpcrp040300-q1r_E30998-000Toy Sales Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥446m
jpcrp040300-q1r_E30998-000Toy Sales Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥446m
jpcrp040300-q1r_E30998-000Toy Sales Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥6m
—segment totalrevenue2024-01-01 → 2024-03-31¥1.0bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥1.0bn
—segment totalsegment profit2024-01-01 → 2024-03-31−¥28m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥48m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥48m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥6m
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥657m
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥609m
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥48m
jpcrp040300-q1r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥60m
jpcrp040300-q1r_E30998-000Toy Sales Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥413m
jpcrp040300-q1r_E30998-000Toy Sales Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥413m
jpcrp040300-q1r_E30998-000Toy Sales Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥3m
—segment totalrevenue2023-01-01 → 2023-03-31¥1.1bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥1.0bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥48m
—segment totalsegment profit2023-01-01 → 2023-03-31−¥62m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 319
ItemContextValueUnit
Long term loans payablePrior1YearInstant1187620000JPY
Long term loans payableCurrentQuarterInstant1120206000JPY
Net defined benefit liabilityPrior1YearInstant76946000JPY
Net defined benefit liabilityCurrentQuarterInstant74898000JPY
Asset retirement obligations nclPrior1YearInstant136949000JPY
Asset retirement obligations nclCurrentQuarterInstant136950000JPY
Other nclPrior1YearInstant10152000JPY
Other nclCurrentQuarterInstant8476000JPY
Noncurrent liabilitiesPrior1YearInstant1411668000JPY
Noncurrent liabilitiesCurrentQuarterInstant1340531000JPY
LiabilitiesPrior1YearInstant3125439000JPY
LiabilitiesCurrentQuarterInstant2788367000JPY
Capital stockPrior1YearInstant142930000JPY
Capital stockCurrentQuarterInstant142930000JPY
Capital surplusPrior1YearInstant1573940000JPY
Capital surplusCurrentQuarterInstant1573940000JPY
Retained earningsPrior1YearInstant-272791000JPY
Retained earningsCurrentQuarterInstant-307692000JPY
Treasury stockPrior1YearInstant-159000JPY
Treasury stockCurrentQuarterInstant-159000JPY
Shareholders equityPrior1YearInstant1443919000JPY
Shareholders equityCurrentQuarterInstant1409018000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1523000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant3760000JPY
Valuation and translation adjustmentsPrior1YearInstant1523000JPY
Valuation and translation adjustmentsCurrentQuarterInstant3760000JPY
Subscription rights to sharesPrior1YearInstant1680000JPY
Subscription rights to sharesCurrentQuarterInstant1680000JPY
Net assetsPrior1YearInstant1447123000JPY
Net assetsCurrentQuarterInstant1414458000JPY
Liabilities and net assetsPrior1YearInstant4572563000JPY
Liabilities and net assetsCurrentQuarterInstant4202826000JPY
Net salesPrior1YTDDuration1021859000JPY
Net salesCurrentYTDDuration1043350000JPY
Cost of salesPrior1YTDDuration714776000JPY
Cost of salesCurrentYTDDuration722537000JPY
Gross profitPrior1YTDDuration307083000JPY
Gross profitCurrentYTDDuration320813000JPY
Selling general and administrative expensesPrior1YTDDuration375425000JPY
Selling general and administrative expensesCurrentYTDDuration347908000JPY
Operating incomePrior1YTDDuration-68342000JPY
Operating incomeCurrentYTDDuration-27095000JPY
Interest income noiPrior1YTDDuration47000JPY
Interest income noiCurrentYTDDuration36000JPY
Commission fee noiPrior1YTDDuration2243000JPY
Commission fee noiCurrentYTDDuration2149000JPY
Subsidy income noi bountyPrior1YTDDuration648000JPY
Subsidy income noi bountyCurrentYTDDuration735000JPY
Cancellation income noiPrior1YTDDuration－JPY
Cancellation income noiCurrentYTDDuration1672000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass